Genetic Sequencing in Cancer
Advances in whole-genome sequencing technology such as copy-number assays are driving significant progress in the diagnosis and treatment of cancer.
Read MorePosted by Jenny Lower | Jan 7, 2015 | Cancer, Molecular Diagnostics |
Advances in whole-genome sequencing technology such as copy-number assays are driving significant progress in the diagnosis and treatment of cancer.
Read MorePosted by Steve Halasey | Nov 18, 2014 | Cancer, Molecular Diagnostics |
Updated ACS guidelines for colorectal cancer include recommended use of a noninvasive stool-based DNA screening test every 3 years.
Read MorePosted by Steve Halasey | Nov 4, 2014 | Research, Respiratory Disease |
In a recent study, the ISET test by Rarecells detected lung cancer in patients with no symptoms, allowing for surgical removal prior to metastasis.
Read MorePosted by Steve Halasey | Oct 28, 2014 | Cancer, Lung Cancer, Molecular Diagnostics |
Biodesix recently announced the inclusion of its VeriStrat profiling test in updated evidence-based, consensus-driven NCCN Guidelines for managing non-small-cell lung cancer.
Read MorePosted by Jenny Lower | Oct 27, 2014 | Cancer, Colorectal, Lung Cancer, Molecular Diagnostics, Unknown Origin & Other Cancer Types |
Vela Diagnostics, Singapore, has announced the availability of the Sentosa SQ Non-Small Cell Lung Cancer panel and the Sentosa Colorectal Cancer panel for next-generation sequencing-based detection of sequence variants, for research use only by early-access customers.
Read More